Neuro-Oncology, 1523-5866

Journal

More filtering options
  1. 2019
  2. Neurologic disorders in 4858 survivors of central nervous system tumors in childhood-an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

    ALiCCS study group, Kenborg, L., Winther, J. F., Linnet, K. M., Krøyer, A., Albieri, V., Anna Sällfors Holmqvist, Tryggvadottir, L., Madanat-Harjuoja, L. M., Stovall, M., Hasle, H. & Olsen, J. H., 2019, In : Neuro-Oncology. 21, 1, p. 125-136 12 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma - A meta-analysis

    Falk Delgado, A., De Luca, F., Danielle Van Westen & Falk Delgado, A., 2018, In : Neuro-Oncology. 20, 11, p. 1450-1461 12 p.

    Research output: Contribution to journalArticle

  5. 2017
  6. Diagnosis and treatment of brain metastases from solid tumors: Guidelines from the European Association of neuro-oncology (EANO)

    Soffietti, R., Abacioglu, U., Baumert, B., Combs, S. E., Kinhult, S., Kros, J. M., Marosi, C., Metellus, P., Radbruch, A., Freixa, S. S. V., Brada, M., Carapella, C. M., Preusser, M., Le Rhun, E., Rudà, R., Tonn, J. C., Weber, D. C. & Weller, M., 2017, In : Neuro-Oncology. 19, 2, p. 162-174 13 p.

    Research output: Contribution to journalArticle

  7. 2016
  8. Development after pediatric brain tumor-a longitudinal study

    Ingrid Tonning Olsson, Lundgren, J., Lars Hjorth & Sean Perrin, 2016 Jun 1, In : Neuro-Oncology. 18, p. 135 1 p.

    Research output: Contribution to journalArticle

  9. 2015
  10. Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.

    Munck af Rosenschöld, P., Costa, J., Engelholm, S. A., Lundemann, M. J., Law, I., Ohlhues, L. & Engelholm, S., 2015, In : Neuro-Oncology. 17, 5, p. 757-763

    Research output: Contribution to journalArticle

  11. Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.

    Danielsen, S. A., Lind, G. E., Kolberg, M., Høland, M., Bjerkehagen, B., Sundby Hall, K., van den Berg, E., Fredrik Mertens, Smeland, S., Picci, P. & Lothe, R. A., 2015, In : Neuro-Oncology. 17, 1, p. 63-69

    Research output: Contribution to journalArticle

  12. TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.

    Simon, M., Hosen, I., Gousias, K., Rachakonda, S., Heidenreich, B., Gessi, M., Schramm, J., Kari Hemminki, Waha, A. & Kumar, R., 2015, In : Neuro-Oncology. 17, 1, p. 45-52

    Research output: Contribution to journalArticle

  13. 2014
  14. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer.

    Andersson, U., Wibom, C., Cederquist, K., Aradottir, S., Borg, Å., Armstrong, G. N., Shete, S., Lau, C. C., Bainbridge, M. N., Claus, E. B., Barnholtz-Sloan, J., Lai, R., Il'yasova, D., Houlston, R. S., Schildkraut, J., Bernstein, J. L., Olson, S. H., Jenkins, R. B., Lachance, D. H., Wrensch, M. & 6 othersDavis, F. G., Merrell, R., Johansen, C., Sadetzki, S., Bondy, M. L. & Melin, B. S., 2014, In : Neuro-Oncology. 16, 10, p. 1333-1340

    Research output: Contribution to journalArticle

Previous 1 2 3 4 Next